Tech article
"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted
Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.
Ars Technica | Jun 17, 2026 | Beth Mole
Tech article
Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.
Ars Technica | Jun 17, 2026 | Beth Mole